Authors:
DENARDO GL
DENARDO SJ
LAMBORN KR
GOLDSTEIN DS
LEVY NB
LEWIS JP
OGRADY LF
RAVENTOS A
KROGER LA
MACEY DJ
MCGAHAN JP
MILLS SL
SHEN S
Citation: Gl. Denardo et al., LOW-DOSE, FRACTIONATED RADIOIMMUNOTHERAPY FOR B-CELL MALIGNANCIES USING I-131 LYM-1 ANTIBODY, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(4), 1998, pp. 239-254
Authors:
DENARDO SJ
KROGER LA
MACKENZIE MR
MIRICK GR
SHEN S
DENARDO GL
Citation: Sj. Denardo et al., PROLONGED SURVIVAL ASSOCIATED WITH IMMUNE-RESPONSE IN A PATIENT TREATED WITH LYM-1 MOUSE MONOCLONAL-ANTIBODY, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(1), 1998, pp. 1-12
Authors:
DENARDO GL
DENARDO SJ
KROGER LA
GOLDSTEIN DS
LAMBORN KR
SHEN S
ODONNELL RT
Citation: Gl. Denardo et al., MILESTONES IN THE DEVELOPMENT OF LYM-1 RADIOIMMUNOTHERAPY, CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 13(1), 1998, pp. 44-44
Authors:
DENARDO GL
KROGER LA
MEARES CF
RICHMAN CM
SALAKO Q
SHEN S
LAMBORN KR
PETERSON JJ
MIERS LA
ZHONG GR
DENARDO SJ
Citation: Gl. Denardo et al., COMPARISON OF 10-TETRAAZACYCLODODECANE-N,N',N'',N'''-TETRAACETIC ACID(DOTA)-PEPTIDE-CHL6, A NOVEL IMMUNOCONJUGATE WITH CATABOLIZABLE LINKER, TO 2-IMINOTHIOLANE-2 [P-(BROMOACETAMIDO)BENZYL]-DOTA-CHL6 IN BREAST-CANCER XENOGRAFTS, Clinical cancer research, 4(10), 1998, pp. 2483-2490
Authors:
SHEN S
TSAI WY
LEUNG R
STRONG E
WONG P
LOUGHLIN KR
ROBBINS PW
GASTON SM
Citation: S. Shen et al., GLCNACTV GENE INTERACTIONS - USE OF YEAST 2 HYBRID TECHNOLOGY TO IDENTIFY PROTEINS IN PROSTATE TISSUES AND IN LNCAP THAT BIND GLCNACTV, Glycobiology, 8(11), 1998, pp. 154-154
Authors:
DENARDO GL
DENARDO SJ
GOLDSTEIN DS
KROGER LA
LAMBORN KR
LEVY NB
MCGAHAN JP
SALAKO Q
SHEN S
LEWIS JP
Citation: Gl. Denardo et al., MAXIMUM-TOLERATED DOSE, TOXICITY, AND EFFICACY OF I-131 LYM-1 ANTIBODY FOR FRACTIONATED RADIOIMMUNOTHERAPY OF NON-HODGKINS-LYMPHOMA, Journal of clinical oncology, 16(10), 1998, pp. 3246-3256
Authors:
DENARDO GL
SHEN S
DENARDO SJ
LIAO SQ
LAMBORN KR
DENARDO DA
YUAN A
Citation: Gl. Denardo et al., QUANTIFICATION OF I-131 IN TUMORS USING A THRESHOLD BASED ON IMAGE-CONTRAST, European journal of nuclear medicine, 25(5), 1998, pp. 497-502
Authors:
DENARDO GL
DENARDO SJ
KUKIS DL
ODONNELL RT
SHEN S
GOLDSTEIN DS
KROGER LA
SALAKO Q
DENARDO DA
MIRICK GR
MAUSNER LF
SRIVASTAVA SC
MEARES CF
Citation: Gl. Denardo et al., MAXIMUM TOLERATED DOSE OF CU-67-2IT-BAT-LYM-1 FOR FRACTIONATED RADIOIMMUNOTHERAPY OF NON-HODGKINS-LYMPHOMA - A PILOT-STUDY, Anticancer research, 18(4B), 1998, pp. 2779-2788
Authors:
SHEN S
DENARDO GL
JONES TD
WILDER RB
ODONNELL RT
DENARDO SJ
Citation: S. Shen et al., A PRELIMINARY CELL-KINETICS MODEL OF THROMBOCYTOPENIA AFTER RADIOIMMUNOTHERAPY, The Journal of nuclear medicine, 39(7), 1998, pp. 1223-1229
Authors:
DENARDO GL
DENARDO SJ
DENARDO DA
SHEN S
MIRICK GR
MACEY DJ
LAMBORN KR
Citation: Gl. Denardo et al., FACTORS AFFECTING I-131 LYM-1 PHARMACOKINETICS AND RADIATION-DOSIMETRY IN PATIENTS WITH NON-HODGKINS-LYMPHOMA (NHL) AND CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL), The Journal of nuclear medicine, 39(5), 1998, pp. 438-438
Authors:
DENARDO SJ
SHEN S
KROGER LA
MIERS LA
RICHMAN CM
KUKIS DL
SALAKO Q
MEARES CF
DENARDO GL
Citation: Sj. Denardo et al., EVIDENCE IN MICE AND PATIENTS THAT A NOVEL PEPTIDE LINKED Y-90 DOTA-CHIMERIC L6 IMMUNOCONJUGATE DECREASED HEPATIC RADIATION-DOSE, The Journal of nuclear medicine, 39(5), 1998, pp. 833-833
Authors:
SHEN S
DENARDO GL
YUAN A
ODONNELL RT
DENARDO SJ
Citation: S. Shen et al., SPLENIC VOLUME, PATIENT-SPECIFIC DOSIMETRY AND THERAPEUTIC RESPONSE FOR PATIENTS TREATED USING RADIOIMMUNOTHERAPY (RIT), The Journal of nuclear medicine, 39(5), 1998, pp. 839-839
Authors:
DENARDO SJ
RICHMAN CM
KUKIS DL
SHEN S
LAMBORN KR
MIERS LA
KROGER LA
DENARDO GL
Citation: Sj. Denardo et al., SYNERGISTIC THERAPY FOR BREAST-CANCER - DEVELOPMENT OF A CLINICAL PROTOCOL FOR RIT AND TAXOL BASED ON CURATIVE THERAPY OF XENOGRAFTED TUMORS AND Y-90 CHL6 PATIENT DOSIMETRY, The Journal of nuclear medicine, 39(5), 1998, pp. 1083-1083
Authors:
DENARDO SJ
KUKIS DL
MIERS LA
WINTHROP MD
KROGER LA
SALAKO Q
SHEN S
LAMBORN KR
GUMERLOCK PH
MEARES CF
DENARDO GL
Citation: Sj. Denardo et al., YTTRIUM-90-DOTA-PEPTIDE CHIMERIC L6 RADIOIMMUNOCONJUGATE - EFFICACY AND TOXICITY IN MICE BEARING P53 MUTANT HUMAN BREAST-CANCER XENOGRAFTS, The Journal of nuclear medicine, 39(5), 1998, pp. 842-849
Citation: Jh. Guo et al., ANGLE MEASUREMENT USING SURFACE-PLASMON-RESONANCE HETERODYNE INTERFEROMETRY - A NEW METHOD, Optical engineering, 37(11), 1998, pp. 2998-3001
Citation: Dx. Liu et al., PROTEOLYTIC MAPPING OF THE CORONAVIRUS INFECTIOUS-BRONCHITIS VIRUS 1B-POLYPROTEIN - EVIDENCE FOR THE PRESENCE OF 4 CLEAVAGE SITES OF THE 3C-LIKE PROTEINASE AND IDENTIFICATION OF 2 NOVEL CLEAVAGE PRODUCTS, Virology (New York, N.Y. Print), 246(2), 1998, pp. 288-297
Citation: S. Shen et Jp. Bourreau, ROLE OF EFFICACY OF MUSCARINIC STIMULATION IN CONTROLLING THE MODE OFEXCITATION-CONTRACTION COUPLING IN SMOOTH-MUSCLE, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 392-392
Citation: Cj. Wurrey et al., CONFORMATIONAL STUDIES OF CYANOMETHYLCYCLOPROPANE FROM TEMPERATURE-DEPENDENT FT-IR SPECTRA OF XENON SOLUTIONS AND AB-INITIO CALCULATIONS, Journal of molecular structure, 449(2-3), 1998, pp. 203-217
Authors:
LAMBORN KR
DENARDO GL
DENARDO SJ
GOLDSTEIN DS
SHEN S
LARKIN EC
KROGER LA
Citation: Kr. Lamborn et al., TREATMENT-RELATED PARAMETERS PREDICTING EFFICACY OF LYM-1 RADIOIMMUNOTHERAPY IN PATIENTS WITH B-LYMPHOCYTIC MALIGNANCIES, Clinical cancer research, 3(8), 1997, pp. 1253-1260
Authors:
DENARDO GL
KUKIS DL
SHEN S
MAUSNER LF
MEARES CF
SRIVASTAVA SC
MIERS LA
DENARDO SJ
Citation: Gl. Denardo et al., EFFICACY AND TOXICITY OF CU-67-2IT-BAT-LYM-1 RADIOIMMUNOCONJUGATE IN MICE IMPLANTED WITH HUMAN BURKITTS-LYMPHOMA (RAJI), Clinical cancer research, 3(1), 1997, pp. 71-79
Authors:
SMITH BA
HALE JR
ZHUKOVSKY A
MICHAEL PC
MINERVINI JV
OLMSTEAD MM
DEKOW GL
ROSATI J
CAMILLE RJ
GUNG CY
GWINN D
SILVA F
FAIRFAX SA
SHEN S
KNOOPERS HG
WESSEL S
KROOSHOOP HJG
SHEVCHENKO OA
GODEKE A
TENKATE HHJ
Citation: Ba. Smith et al., PTF, A NEW FACILITY FOR PULSE FIELD TESTING OF LARGE-SCALE SUPERCONDUCTING CABLES AND JOINTS, IEEE transactions on applied superconductivity, 7(2), 1997, pp. 1049-1052
Authors:
ECELBARGER CA
FERNANDEZLLAMA P
LEE AJ
NIELSEN S
WARE JA
SHEN S
POHL LR
KNEPPER MA
Citation: Ca. Ecelbarger et al., ENHANCEMENT OF URINARY CONCENTRATING ABILITY BY CYCLOOXYGENASE INHIBITORS IS ASSOCIATED WITH INCREASED EXPRESSION OF NA-K-2CL COTRANSPORTERAND INCREASED TRAFFICKING OF AQUAPORIN-2 WATER CHANNEL, Journal of the American Society of Nephrology, 8, 1997, pp. 1913-1913
Citation: Xx. Yang et al., THE DEGENERATE SOLUTION FOR PIEZOTHERMOELASTIC MATERIALS, European journal of mechanics. A, Solids, 16(5), 1997, pp. 779-793
Authors:
SHEN S
DENARDO GL
MACEY DJ
ODONNELL RT
YUAN A
DENARDO DA
DENARDO SJ
Citation: S. Shen et al., PRACTICAL DETERMINATION OF ORGAN S-VALUE FOR INDIVIDUAL PATIENTS FOR THERAPY, Nuclear medicine and biology, 24(5), 1997, pp. 447-449